China In-Focus: China-Biotics Names Fan As CFO
Prior to joining China-Biotics, Fan was VP and senior equity analyst for Brean Murray, Carret & Co., where he covered the Chinese healthcare industry. He previously served as an equity analyst at UBS (NYSE: UBS) and as an emerging markets strategist at Deutsche Bank (NYSE: DB).
Prior to his Wall Street career, Fan served as a research scientist focusing on natural product drug discovery at Schering-Plough.
Shanghai-based China-Biotics is a manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements.
The company's proprietary product portfolio contains live microbial nutritional supplements under the "Shining" brand. Its products are sold OTC through large distributors to pharmacies and supermarkets in Shanghai, Jiangsu, and Zhejiang. China-Biotics plans to launch 300 Shining brand retail outlets in major cities in China.
Currently, China-Biotics is strategically expanding its production capacity of probiotics to meet growing demand in the bulk additive market.
FinancialWire" ( http://www.financialwire.net ), an independent, proprietary news service of Investrend Communications, Inc., receives no compensation for its news or opinions. Further disclosure is at http://www.investrend.com/articles/secondlevel.asp?level=472 . To contact FinancialWire" write to inquiries@financialwire.net .
Free annual reports for companies mentioned in the news are accessible via http://investrend.ar.wilink.com/?level=279 .
Copyright(C)2009 by financialwire.net, Inc. All rights reserved.
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.
